Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 41

    1.

    Impact of The PPAR-{gamma}2 Pro12Ala polymorphism and ACE inhibitor therapy on new-onset microalbuminuria in type 2 Diabetes: evidence from Benedict.

    De Cosmo S, Motterlini N, Prudente S, Pellegrini F, Trevisan R, Bossi A, Remuzzi G, Trischitta V, Ruggenenti P; on behalf of the BENEDICT Study Group.

    Diabetes. 2009 Aug 31. [Epub ahead of print]PMID: 19720797 [PubMed - as supplied by publisher]Related articles

    2.

    Obesity and changes in urine albumin/creatinine ratio in patients with type 2 diabetes: The DEMAND Study.

    Rossi MC, Nicolucci A, Pellegrini F, Comaschi M, Ceriello A, Cucinotta D, Giorda C, Pomili B, Valentini U, Vespasiani G, De Cosmo S.

    Nutr Metab Cardiovasc Dis. 2009 May 15. [Epub ahead of print]PMID: 19447588 [PubMed - as supplied by publisher]Related articles

    3.

    Association of the Q121 variant of ENPP1 gene with decreased kidney function among patients with type 2 diabetes.

    De Cosmo S, Minenna A, Zhang YY, Thompson R, Miscio G, Vedovato M, Rauseo A, Saller A, Mastroianno S, Pellegrini F, Trevisan R, Fioretto P, Doria A, Trischitta V.

    Am J Kidney Dis. 2009 Feb;53(2):273-80. Epub 2008 Oct 31.PMID: 18950909 [PubMed - indexed for MEDLINE]Related articles

    4.

    Metabolic syndrome is not a risk factor for kidney dysfunction in obese non-diabetic subjects.

    Gatti A, Morini E, De Cosmo S, Maiani F, Mandosi E, Fallarino M, Morano S, Trischitta V.

    Obesity (Silver Spring). 2008 Apr;16(4):899-901. Epub 2008 Jan 31.PMID: 18239564 [PubMed - indexed for MEDLINE]Related articles

    5.

    A polymorphism at the IL6ST (gp130) locus is associated with traits of the metabolic syndrome.

    Gottardo L, De Cosmo S, Zhang YY, Powers C, Prudente S, Marescotti MC, Trischitta V, Avogaro A, Doria A.

    Obesity (Silver Spring). 2008 Jan;16(1):205-10.PMID: 18223637 [PubMed - indexed for MEDLINE]Related articles

    6.

    Interaction of DIO2 T92A and PPARgamma2 P12A polymorphisms in the modulation of metabolic syndrome.

    Fiorito M, Torrente I, De Cosmo S, Guida V, Colosimo A, Prudente S, Flex E, Menghini R, Miccoli R, Penno G, Pellegrini F, Tassi V, Federici M, Trischitta V, Dallapiccola B.

    Obesity (Silver Spring). 2007 Dec;15(12):2889-95.PMID: 18198294 [PubMed - indexed for MEDLINE]Related articles

    7.

    Identifying patients with type 2 diabetes at high risk of microalbuminuria: results of the DEMAND (Developing Education on Microalbuminuria for Awareness of reNal and cardiovascular risk in Diabetes) Study.

    Rossi MC, Nicolucci A, Pellegrini F, Comaschi M, Ceriello A, Cucinotta D, Giorda C, Valentini U, Vespasiani G, De Cosmo S.

    Nephrol Dial Transplant. 2008 Apr;23(4):1278-84. Epub 2007 Nov 26.PMID: 18039647 [PubMed - indexed for MEDLINE]Related articles

    8.

    Glutamine to arginine substitution at amino acid 84 of mammalian tribbles homolog TRIB3 and CKD in whites with type 2 diabetes.

    De Cosmo S, Prudente S, Andreozzi F, Morini E, Rauseo A, Scarpelli D, Zhang YY, Xu R, Perticone F, Dallapiccola B, Sesti G, Doria A, Trischitta V.

    Am J Kidney Dis. 2007 Oct;50(4):688-9. No abstract available. PMID: 17900474 [PubMed - indexed for MEDLINE]Related articles

    9.

    Akt2 Gene common allelic variants in insulin resistance and the metabolic syndrome.

    Tassi V, Coco A, Padovano L, De Bonis C, De Cosmo S, Trischitta V.

    Nutr Metab Cardiovasc Dis. 2008 May;18(4):263-70. Epub 2007 Jun 18.PMID: 17576055 [PubMed - indexed for MEDLINE]Related articles

    10.

    ENPP1 gene, insulin resistance and related clinical outcomes.

    Bacci S, De Cosmo S, Prudente S, Trischitta V.

    Curr Opin Clin Nutr Metab Care. 2007 Jul;10(4):403-9. Review.PMID: 17563456 [PubMed - indexed for MEDLINE]Related articles

    11.

    Role of PC-1 and ACE genes on insulin resistance and cardiac mass in never-treated hypertensive patients. Suggestive evidence for a digenic additive modulation.

    Perticone F, Maio R, Di Paola R, Sciacqua A, Marucci A, De Cosmo S, Perticone M, Sesti G, Trischitta V.

    Nutr Metab Cardiovasc Dis. 2007 Mar;17(3):181-7. Epub 2006 Mar 20.PMID: 17367703 [PubMed - indexed for MEDLINE]Related articles

    12.

    A functional variant of the adipocyte glycerol channel aquaporin 7 gene is associated with obesity and related metabolic abnormalities.

    Prudente S, Flex E, Morini E, Turchi F, Capponi D, De Cosmo S, Tassi V, Guida V, Avogaro A, Folli F, Maiani F, Frittitta L, Dallapiccola B, Trischitta V.

    Diabetes. 2007 May;56(5):1468-74. Epub 2007 Mar 9.PMID: 17351148 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Cigarette smoking is associated with low glomerular filtration rate in male patients with type 2 diabetes.

    De Cosmo S, Lamacchia O, Rauseo A, Viti R, Gesualdo L, Pilotti A, Trischitta V, Cignarelli M.

    Diabetes Care. 2006 Nov;29(11):2467-70.PMID: 17065686 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Heritability of serum resistin and its genetic correlation with insulin resistance-related features in nondiabetic Caucasians.

    Menzaghi C, Coco A, Salvemini L, Thompson R, De Cosmo S, Doria A, Trischitta V.

    J Clin Endocrinol Metab. 2006 Jul;91(7):2792-5. Epub 2006 May 2.PMID: 16670163 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Insulin resistance and the cluster of abnormalities related to the metabolic syndrome are associated with reduced glomerular filtration rate in patients with type 2 diabetes.

    De Cosmo S, Trevisan R, Minenna A, Vedovato M, Viti R, Santini SA, Dodesini AR, Fioretto P, Trischitta V.

    Diabetes Care. 2006 Feb;29(2):432-4. No abstract available. PMID: 16443904 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    The functional Q84R polymorphism of mammalian Tribbles homolog TRB3 is associated with insulin resistance and related cardiovascular risk in Caucasians from Italy.

    Prudente S, Hribal ML, Flex E, Turchi F, Morini E, De Cosmo S, Bacci S, Tassi V, Cardellini M, Lauro R, Sesti G, Dallapiccola B, Trischitta V.

    Diabetes. 2005 Sep;54(9):2807-11.PMID: 16123373 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Increased urinary albumin excretion, insulin resistance, and related cardiovascular risk factors in patients with type 2 diabetes: evidence of a sex-specific association.

    De Cosmo S, Minenna A, Ludovico O, Mastroianno S, Di Giorgio A, Pirro L, Trischitta V.

    Diabetes Care. 2005 Apr;28(4):910-5.PMID: 15793194 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Lack of evidence for the 1484insG variant at the 3'-UTR of the protein tyrosine phosphatase 1B (PTP1B) gene as a genetic determinant of diabetic nephropathy development in type 1 diabetic patients.

    De Cosmo S, Marucci A, Ciociola E, Di Paola R, Pucci L, Penno G, Del Prato S, Piras GP, Trevisan R, Giunti S, Viberti GC, Trischitta V.

    Nephrol Dial Transplant. 2004 Sep;19(9):2419-20. No abstract available. PMID: 15299110 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    The allelic variant of LAR gene promoter -127 bp T-->A is associated with reduced risk of obesity and other features related to insulin resistance.

    Miscio G, Tassi V, Coco A, Soccio T, Di Paola R, Prudente S, Baratta R, Frittitta L, Ludovico O, Padovano L, Dallapiccola B, Di Mario U, De Cosmo S, Trischitta V.

    J Mol Med. 2004 Jul;82(7):459-66. Epub 2004 May 19.PMID: 15150650 [PubMed - indexed for MEDLINE]Related articles

    20.

    PC-1 amino acid variant Q121 is associated with a lower glomerular filtration rate in type 2 diabetic patients with abnormal albumin excretion rates.

    De Cosmo S, Trevisan R, Dalla Vestra M, Vedovato M, Argiolas A, Solini A, Saller A, Damone F, Tiengo A, Trischitta V, Fioretto P.

    Diabetes Care. 2003 Oct;26(10):2898-902.PMID: 14514598 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Screening for silent myocardial ischaemia in type 2 diabetic patients with additional atherogenic risk factors: applicability and accuracy of the exercise stress test.

    Bacci S, Villella M, Villella A, Langialonga T, Grilli M, Rauseo A, Mastroianno S, De Cosmo S, Fanelli R, Trischitta V.

    Eur J Endocrinol. 2002 Nov;147(5):649-54.PMID: 12444897 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Podocyte number in normotensive type 1 diabetic patients with albuminuria.

    White KE, Bilous RW, Marshall SM, El Nahas M, Remuzzi G, Piras G, De Cosmo S, Viberti G.

    Diabetes. 2002 Oct;51(10):3083-9.PMID: 12351451 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    The Decorin gene 179 allelic variant is associated with a slower progression of renal disease in patients with type 1 diabetes.

    De Cosmo S, Tassi V, Thomas S, Piras GP, Trevisan R, Cavallo Perin P, Bacci S, Zucaro L, Cisternino C, Trischitta V, Viberti GC.

    Nephron. 2002 Sep;92(1):72-6.PMID: 12187087 [PubMed - indexed for MEDLINE]Related articles

    24.

    The role of PC-1 and ACE genes in diabetic nephropathy in type 1 diabetic patients: evidence for a polygenic control of kidney disease progression.

    De Cosmo S, Miscio G, Zucaro L, Margaglione M, Argiolas A, Thomas S, Piras G, Trevisan R, Perin PC, Bacci S, Frittitta L, Pizzuti A, Tassi V, Di Minno G, Viberti G, Trischitta V.

    Nephrol Dial Transplant. 2002 Aug;17(8):1402-7.PMID: 12147786 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Role of insulin-like growth factor (IGF)-1 in the modulation of renal haemodynamics in Type I diabetic patients.

    Bacci S, De Cosmo S, Garruba M, Placentino G, Liuzzi A, Barbano F, Di Giorgio A, Trischitta V, Viberti GC.

    Diabetologia. 2000 Jul;43(7):922-6.PMID: 10952466 [PubMed - indexed for MEDLINE]Related articles

    26.

    A PC-1 amino acid variant (K121Q) is associated with faster progression of renal disease in patients with type 1 diabetes and albuminuria.

    De Cosmo S, Argiolas A, Miscio G, Thomas S, Piras GP, Trevisan R, Perin PC, Bacci S, Zucaro L, Margaglione M, Frittitta L, Pizzuti A, Tassi V, Viberti GC, Trischitta V.

    Diabetes. 2000 Mar;49(3):521-4.PMID: 10868979 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    ACE, PAI-1, decorin and Werner helicase genes are not associated with the development of renal disease in European patients with type 1 diabetes.

    De Cosmo S, Margaglione M, Tassi V, Garrubba M, Thomas S, Olivetti C, Piras GP, Trevisan R, Vedovato M, Cavallo Perin P, Bacci S, Colaizzo D, Cisternino C, Zucaro L, Di Minno G, Trischitta V, Viberti GC.

    Diabetes Metab Res Rev. 1999 Jul-Aug;15(4):247-53.PMID: 10495473 [PubMed - indexed for MEDLINE]Related articles

    28.

    Gastrointestinal motor dysfunction, symptoms, and neuropathy in noninsulin-dependent (type 2) diabetes mellitus.

    Annese V, Bassotti G, Caruso N, De Cosmo S, Gabbrielli A, Modoni S, Frusciante V, Andriulli A.

    J Clin Gastroenterol. 1999 Sep;29(2):171-7.PMID: 10478880 [PubMed - indexed for MEDLINE]Related articles

    29.

    High prevalence of risk factors for cardiovascular disease in parents of IDDM patients with albuminuria.

    De Cosmo S, Bacci S, Piras GP, Cignarelli M, Placentino G, Margaglione M, Colaizzo D, Di Minno G, Giorgino R, Liuzzi A, Viberti GC.

    Diabetologia. 1997 Oct;40(10):1191-6.PMID: 9349601 [PubMed - indexed for MEDLINE]Related articles

    30.

    Renal functional response to protein loading in type 1 (insulin-dependent) diabetic patients on normal or high salt intake.

    Lopes de Faria JB, Friedman R, de Cosmo S, Dodds RA, Mortton JJ, Viberti GC.

    Nephron. 1997;76(4):411-7.PMID: 9274838 [PubMed - indexed for MEDLINE]Related articles

    31.

    Glucose-induced changes in renal haemodynamics in proteinuric type 1 (insulin-dependent) diabetic patients: inhibition by acetylsalicilic acid infusion.

    De Cosmo S, Earle K, Morocutti A, Walker J, Ruggenenti P, Remuzzi G, Viberti GC.

    Diabetologia. 1993 Jul;36(7):622-7.PMID: 8359579 [PubMed - indexed for MEDLINE]Related articles

    32.

    Effect of selective inhibition of thromboxane synthesis on renal function in diabetic nephropathy.

    Kontessis PS, Jones SL, Barrow SE, Stratton PD, Alessandrini P, De Cosmo S, Ritter JM, Viberti GC.

    J Lab Clin Med. 1993 Mar;121(3):415-23.PMID: 8445289 [PubMed - indexed for MEDLINE]Related articles

    33.

    Comparison of glucose counterregulation during short-term and prolonged hypoglycemia in normal humans.

    De Feo P, Perriello G, De Cosmo S, Ventura MM, Campbell PJ, Brunetti P, Gerich JE, Bolli GB.

    Diabetes. 1986 May;35(5):563-9.PMID: 2869997 [PubMed - indexed for MEDLINE]Related articles

    34.

    Role of hepatic autoregulation in defense against hypoglycemia in humans.

    Bolli G, De Feo P, Perriello G, De Cosmo S, Ventura M, Campbell P, Brunetti P, Gerich JE.

    J Clin Invest. 1985 May;75(5):1623-31.PMID: 2860128 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    [Effects of circulating anti-insulin antibodies on the kinetics of injected insulin in type I diabetes mellitus]

    Bolli GB, De Feo P, Perriello G, Ventura MM, De Cosmo S, Calafiore R, Pietropaolo M, Basta G, Lolli C, Batta M.

    Recenti Prog Med. 1985 Jan;76(1):2-5. Italian. No abstract available. PMID: 3887513 [PubMed - indexed for MEDLINE]Related articles

    36.

    Demonstration of a dawn phenomenon in normal human volunteers.

    Bolli GB, De Feo P, De Cosmo S, Perriello G, Ventura MM, Calcinaro F, Lolli C, Campbell P, Brunetti P, Gerich JE.

    Diabetes. 1984 Dec;33(12):1150-3.PMID: 6389230 [PubMed - indexed for MEDLINE]Related articles

    37.

    A reliable and reproducible test for adequate glucose counterregulation in type I diabetes mellitus.

    Bolli GB, De Feo P, De Cosmo S, Perriello G, Ventura MM, Benedetti MM, Santeusanio F, Gerich JE, Brunetti P.

    Diabetes. 1984 Aug;33(8):732-7.PMID: 6378698 [PubMed - indexed for MEDLINE]Related articles

    38.

    [Prospective evaluation of the insulin infusion test to establish the adequacy of glucose counterregulation during hypoglycemia in type 1 diabetics undergoing intensive insulin therapy]

    Bolli G, De Feo P, Perriello G, De Cosmo S, Compagnucci P, Ventura MM, Santeusanio F, Gerich JE, Brunetti P.

    Minerva Endocrinol. 1984 Apr-Jun;9(2):101-5. Italian. No abstract available. PMID: 6390121 [PubMed - indexed for MEDLINE]Related articles

    39.

    Mechanisms of glucagon secretion during insulin-induced hypoglycemia in man. Role of the beta cell and arterial hyperinsulinemia.

    Bolli G, De Feo P, Perriello G, De Cosmo S, Compagnucci P, Santeusanio F, Brunetti P, Unger RH.

    J Clin Invest. 1984 Apr;73(4):917-22.PMID: 6368593 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Effects of long-term optimization and short-term deterioration of glycemic control on glucose counterregulation in type I diabetes mellitus.

    Bolli G, De Feo P, De Cosmo S, Perriello G, Angeletti G, Ventura MR, Santeusanio F, Brunetti P, Gerich JE.

    Diabetes. 1984 Apr;33(4):394-400.PMID: 6368295 [PubMed - indexed for MEDLINE]Related articles

    41.

    The adrenergic contribution to glucose counterregulation in type I diabetes mellitus. Dependency on A-cell function and mediation through beta 2-adrenergic receptors.

    De Feo P, Bolli G, Perriello G, De Cosmo S, Compagnucci P, Angeletti G, Santeusanio F, Gerich JE, Motolese M, Brunetti P.

    Diabetes. 1983 Oct;32(10):887-93.PMID: 6311652 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...